AzTrials
AzTrials

Sport InjuryNCT06695728

Hybrid Assistive Limb Effect on Jump Height: a Clinical Study

A study testing exercise in people with Sport Injury, run by Uskudar University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the effect of exercises performed with The Hybrid Assistive Limb device on the jump height of healthy non-athlete individuals. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Sport Injury
What is being tested?
exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
19 Nov 2024to 23 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being between 20 and 40 years old.
  • Tall individuals over 120 cm (for accurate visual feedback in the assessment of jump height)
  • Weighting less than 100 kg
  • People who can perceive and follow the given instructions without any problems
  • People who have not had any surgery in the last 6 months
  • People who are not allergic to electrodes
Show all 16Show fewer
  • They should not have any skin tissue related disorders.
  • People who do not use pacemakers
  • People who do not have a history of seizures or a risk of seizures (epilepsy).
  • They should not have heart and respiratory problems.
  • People who have not experienced back pain in the last 3 months.
  • People whose waist circumference is not more than 120 cm and whose thigh circumference is not more than 80 cm.
  • No orthopedic or neurological problems that will affect the balance mechanism (e.g. Vertigo, cerebellum damage, ataxia).
  • Not having used a Waist Type Hybrid Assistive Limb device before
  • Not having worked with visual feedback devices such as Tecnobody D-Wall before
  • Not having worked with any of the Cyberdyne Hybrid Assistive Limb devices before

Who cannot join

  • People with back pain or who have had surgery on their back
  • Having had surgery within the last 6 months.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Cybernıcx

    Istanbul

Other trials in Turkey (Türkiye)

About this study

The aim of this study is to investigate the effect of exercises performed with The Hybrid Assistive Limb device on the jump height of healthy non-athlete individuals.

Read the detailed description

Cyberdyne Waist Type device will be worn by attaching 3 electrodes to the waist area and then attaching the device to the waist and legs with the help of belts. Then, the appropriate modes will be selected for the participant with the adjustments made on the device. It has 3 modes; CVC, the mode that produces torque value, that is, movement, according to muscle activation with only the bioelectric signals received from the person's skin. CAC, the mode that produces movement by presenting automatic values to the participant with data designed according to the specific software and algorithm of the device. CIC, the mode that produces movement completely according to the participant's control. In our study, investigators will produce movement according to the muscle activation created by the participant using the CVC mode. In this way, investigators will provide the brain-muscle relationship and motor learning parameters. The exercises will be applied for 30 minutes, 5 days a week, for a total of 40 sessions.

Conditions
Sport Injury
Being tested
exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • exerciseOther

    It consists of exercises to be done with the exoskeleton. These are; jumping exercise, squat, sit-stand and forward bending exercises.

Study groups in NCT06695728
Study groupRoleWhat they receive
Hybrid Assistive Limb GroupExperimentalexoskeleton
Receives: Other: exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. D-Wall (TecnoBody SRL, Italy)

    D-Wall (TecnoBody SRL, Italy) is a digital mirror device consisting of a powerful platform paired with a control computer and a high-resolution 3D Kinect camera equipped with infrared beams that allow for motion capture. The system provides instant feedback on the patient's movements on a large LCD monitor, offering VR-based mirror therapy and game-based exercises.This device measures the jump height and the amount of power consumed. It records the data and presents the result numerically.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2024
  2. Study start19 Nov 2024
  3. Primary completion20 Jan 2025
  4. Study completion23 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06695728
Sponsor's protocol ID
Uskudar16
Status last verified
Feb 2025
First submitted
14 Nov 2024
Last updated
25 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Moll F, Kessel A, Bonetto A, Stresow J, Herten M, Dudda M, Adermann J. Use of Robot-Assisted Gait Training in Pediatric Patients with Cerebral Palsy in an Inpatient Setting-A Randomized Controlled Trial. Sensors (Basel). 2022 Dec 16;22(24):9946. doi: 10.3390/s22249946.

    PubMed 36560316
  • Watanabe H, Tsurushima H, Yanagi H. Effect of hybrid assistive limb treatment on maximal walking speed and six-minute walking distance during stroke rehabilitation: a pilot study. J Phys Ther Sci. 2021 Feb;33(2):168-174. doi: 10.1589/jpts.33.168. Epub 2021 Feb 13.

    PubMed 33642694
  • Matsuda M, Iwasaki N, Mataki Y, Mutsuzaki H, Yoshikawa K, Takahashi K, Enomoto K, Sano K, Kubota A, Nakayama T, Nakayama J, Ohguro H, Mizukami M, Tomita K. Robot-assisted training using Hybrid Assistive Limb(R) for cerebral palsy. Brain Dev. 2018 Sep;40(8):642-648. doi: 10.1016/j.braindev.2018.04.004. Epub 2018 Jul 14.

    PubMed 29773349

Questions about this trial

What is this clinical trial studying?

A study testing exercise in people with Sport Injury, run by Uskudar University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

D-Wall (TecnoBody SRL, Italy) (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06695728, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in